Anatomy and Physiology of the Peritoneal Membrane
1998; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês
10.1111/j.1525-139x.1998.tb00210.x
ISSN1525-139X
AutoresJanice A. Nagy, Robert W. Jackman,
Tópico(s)Central Venous Catheters and Hemodialysis
ResumoSeminars in DialysisVolume 11, Issue 1 p. 49-56 Anatomy and Physiology of the Peritoneal Membrane Janice A. Nagy, Corresponding Author Janice A. Nagy Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MassachusettsAddress correspondence to: Janice A. Nagy Ph.D., Department of Pathology, Beth Israel Deaconess Medical Center, Research North Building, 99 Brookline Avenue, Boston, MA 02215. Email: [email protected]Search for more papers by this authorRobert W. Jackman, Robert W. Jackman Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MassachusettsSearch for more papers by this author Janice A. Nagy, Corresponding Author Janice A. Nagy Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MassachusettsAddress correspondence to: Janice A. Nagy Ph.D., Department of Pathology, Beth Israel Deaconess Medical Center, Research North Building, 99 Brookline Avenue, Boston, MA 02215. Email: [email protected]Search for more papers by this authorRobert W. Jackman, Robert W. Jackman Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MassachusettsSearch for more papers by this author First published: 01 October 2007 https://doi.org/10.1111/j.1525-139X.1998.tb00210.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gokal R, Nolph KD: Historical developments and overview of peritoneal dialysis, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht , The Netherlands , Kluwer Academic Publishers, 1994, pp. 1–15. 2 Rippe B, Krediet RT: Peritoneal physiology-transport of solutes, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht . The Netherlands , Kluwer Academic Publishers, 1994, pp. 69–113. 3 Honda K, Nitta K, Horita S, Yumura W, Nihei H: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72: 171–176, 1996. 4 Coles GA, Williams JD: The management of ultrafiltration failure in peritoneal dialysis. Kidney Int 46: S14–S17, 1994. 5 Vargemezis V, Hatjibougias J, Tsagaris TH, Kaldrimidou E, Pasadakis P, Thodis E, Eftimiadou A, Bouricas G: Morphological changes of peritoneal membrane in patients on CAPD with early signs of ultrafiltration loss, in Current Concepts in Peritoneal Dialysis, edited by K. Ota Elsevier Science Publishers, 1992, pp. 89–98. 6 Rubin J, Clawson M, Planch A, Jones Q: Measurements of peritoneal surface area in man and rat. Am J Med Sci 295: 453–458, 1988. 7 Fawcett DW: Epithelium, in A Textbook of Histology, edited by W Bloom, DW. Fawcett Philadelphia , W.B. Saunders, 1986, pp. 59. 8 Dobbie JW: Ultrastructure and pathology of the peritoneum in peritoneal dialysis, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht , The Netherlands , Kluwer Academic Publishers, 1994, pp. 17–44. 9 Simionescu M, Simionescu N: Organizations of cell junctions in the peritoneal mesothelium. J Cell Biol 74: 98–110, 1977. 10 Whitaker D, Papadimitriou JM, Walters MNI: The mesothelium and its reactions: A review. CRC Critical Reviews in Toxicology 10: 81–144, 1982. 11 Nose A, Takeichi M: A novel cadherin cell adhesion molecule: Its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103: 2649–2658, 1986. 12 Linnainmaa K, Pelin K, Vanhala E, Tuomi T, Piccoli C, Fitzgerald DJ, Yamasaki H: Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells. Carcinogenesis 14: 1597–1602, 1993. 13 Davila RM, Crouch EC: Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 142: 547–555, 1993. 14 Rennard SI, Jaurand MC, Bignon J, Kawanami O, Ferrans VJ, Davidson J, Crystal RG: Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 130: 267–274, 1984. 15 White R, Korthuis R, Granger DN: The peritoneal microcirculation in peritoneal dialysis, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht , The Netherlands , Kluwer Academic Publishers, 1994, pp. 45–68. 16 Mactier RA, Khanna R: Peritoneal Lymphatics, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht , The Netherlands , Kluwer Academic Publishers, 1994, pp. 115–134. 17 Nagy J: Peritoneal membrane morphology and function. Kidney Int 50: S2–S11, 1996. 18 Andrews PM, Porter KR: The ultrastructural morphology and possible significance of mesothelial microvilli. Anat Rec 177: 409–426, 1973. 19 Yung S, Coles GA, Williams JD, Davies M: The source and possible significance of hyaluronic acid in the peritoneal cavity. Kidney Int 46: 527–533, 1994. 20 Yung S, Thomas GJ, Stylianou E, Williams JD, Coles GA, Davies M: Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 146: 520–529, 1995. 21 Dobbie JW, Pavlina T, Lloyd J, Johnson RC: Phosphatidylcholine synthesis by peritoneal mesothelium: its implications for peritoneal dialysis. Am J Kid Dis 12: 31–36, 1988. 22 Nolph KD, Miller F, Rubin J, Popovich R: New directions in peritoneal dialysis concepts and applications. Kidney Int 18: S111–S116, 1980. 23 Cotran RS, Karnovsky M: Ultrastructural studies on the permeability of the mesothelium to horse radish peroxidase. J Cell Biol 37: 123–137, 1968. 24 Gotloib L, Shostak A: Peritoneal ultrastructure, in Peritoneal Dialysis ( 3rd ed.), edited by KD. Nolph Amsterdam , Nijhoff, 1989, pp. 67–95. 25 Gotloib L, Shostak A: Endocytosis and transcytosis of albumin gold through mice peritoneal mesothelium. Kidney Int 47: 1274–1284, 1995. 26 Lloyd JK, Hauck WN, Dobbie JW: Comparative ultrastructural studies on animal peritoneal mesothelium, in Advances in peritoneal dialysis. Proceedings of the eighth annual CAPD conference, edited by R Khanna, KD Nolph, B Prowant, ZJ Twardowski, DG. Oreopoulos Toronto , University of Toronto Press, 1988, pp. 27–31. 27 Whitaker D, Papadimitriou JM, Walters MNI: The mesothelium: Its fibrinolytic properties. J Pathol 136: 291–299, 1982. 28 Ryan GB, Grobety J, Majno G: Postoperative peritoneal adhesions. Am J Pathol 65: 133–134, 1971. 29 Holmdahl L, Falkenberg M, Ivarsson M, Risberg B: Plasminogen activators and inhibitors in peritoneal tissue. APMIS 105: 25–30, 1997. 30 Van Hinsbergh VWM, Kooistra T, Scheffer MA, Van Bockel JH, Van Muijen GNP: Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 75: 1490–1497, 1990. 31 Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR: Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7: 414–426, 1992. 32 Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T: Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 271: R1256–R1263, 1996. 33 Moore KL, Bang NU, Broadie TA, Mattler LF, Marks CA: Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. J Lab Clin Med 101: 921–929, 1983. 34 Pugatch EMJ, Foster EA, Macfarlane DE, Poole JCF: The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mesothelium. Br J Haematol 18: 669–681, 1970. 35 Rheinwald JG, Jorgensen JL, Hahn WC, Terpstra AJ, O'Connell TM, Plummer KK: Mesosecrin: A secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture. J Cell Biol 104: 263–275, 1987. 36 Whawell SA, Thompson JN: Cytokine-induced release of plasminogen activator-1 by human mesothelial cells. Eur J Surg 161: 315–317, 1995. 37 Whawell SA, Wang Y, Fleming KA, Thompson EM, Thompson JN: Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J Pathol 169: 67–71, 1993. 38 Sitter T, Godde M, Spannag M, Fricke H, Kooistra T: Intraperitoneal coagulation and fibrinolysis during inflammation: in vivo and in vitro observations. Fibrinolysis 10: 99–104, 1996. 39 Hau T, Payne WD, Simmins RL: Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynec Obstet 148: 415–418, 1979. 40 Holmdahl L, Eriksson E, Al-Jabreen M, Risberg B: Fibrinolysis in human peritoneum during operation. Surgery 119: 701–705, 1996. 41 Pronk A, De Groot PG, Hoynck van Papendrecht AA, Verbrugh HA, Leguit P, Van Vroonhoven TJ, Sixma JJ: Thrombogenicity and procoagulant activity of human mesothelial cells. Arteriosclerosis Thromb 12: 1428–1436, 1992. 42 Nicholson LJ, Clarke JMF, Pittilo RM, Machin SJ, Woolf N: The mesothelial cell as a non-thrombogenic surface. Thromb Haemostas 52: 102–104, 1984. 43 Kumar A, Koenig K, Johnson A, Idell S: Expression and assembly of procoagulant complexes by human pleural mesothelial cells. Thrombosis and Haemostasis 71: 587–592, 1994. 44 Verhagen HJM, Heijnen-Snyder GJ, Vink T, Pronk A, Van Vroonhoven TJMV, Eikelboom BC, Sixma JJ, De Groot PG: Tissue factor expression on mesothelial cells is induced during in vitro culture- Manipulation of culture conditions creates perspectives for mesothelial cells as a source for cell seeding procedures on vascular grafts. Thromb Haemostasis 74: 1096–1102, 1995. 45 Sitter T, Spannagl M, Schiffl H, Held E, Van Hinsbergh VWM, Kooistra T: Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 10: 677–683, 1995. 46 Parsoo I, Haffeie AA, Naicker S: Intestinal obstructions due to adhesions complicating CAPD. Peritoneal Dial Bull 3: 43, 1983. 47 Dobbie JW, Zaki MA: The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD, in Frontiers in Peritoneal Dialysis, edited by JF Maher, JF. Winchester New York , Field, Rich and Assoc, 1986, pp. 3–10. 48 Ing TS, Daugirdas JT, Gandhi VC: Peritoneal sclerosis in peritoneal dialysis patients. Am J Nephrol 4: 173–176, 1984. 49 Gandhi VC, Ing TS, Daugirdas JT, Blumenkrantz MJ, Hagen C, Jablokow VR: Failure of peritoneal dialysis due to peritoneal sclerosis. Int J Artif Organs 6: 97, 1983. 50 Slingeneyer A, Canaud B, Mourad G, Beraud JJ, Balmes M, Mion C: Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Internal Organs 29: 633–638, 1983. 51 Kuwahara M, Kuwahara M, Bijwaard KE, Gersten DM, Diglio CA, Kagan E: Mesothelial cells produce a chemoattractant for lung fibroblasts: Role of fibronectin. Am J Respir Cell Mol Biol 5: 256–264, 1991. 52 Kuwahara M, Kuwahara M, Suzuki N: Production of endothelin-1 and big-endothelin-1 by pleural mesothelial cells. FEBS Lett 298: 21–24, 1992. 53 Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Paul K, Grage B, Schmahl M, Knabbe C: Transforming growth factor-β synthesis by human peritoneal mesothelial. Am J Pathol 148: 1679–1688, 1996. 54 Kumano K, Shimoda M, Hyodo T, Sakai T: The role of TGF-β growth inhibition of peritoneal mesothelial cells in high-glucose dialysate. Per Dial Int 15: S93–S95, 1995. 55 Heldin P, Suzuki M, Teder P, Pertoft H: Chondroitin sulfate proteoglycan modulates the permeability of hyaluronan-containing coats around normal human mesothelial cells. J Cell Physiol 165: 54–61, 1995. 56 Milligan SA, Owens MW, Henderson RJJ, Grimes SR: Characterization of proteoglycans produced by rat pleural mesothelial cells in vitro. Exp Lung Res 21: 559–575, 1995. 57 Ferriola PC, Stewart W: Fibronectin expression and organization in mesothelial cells. Am J Physiol Lung Cell Mol Physiol 15: L804–L812, 1996. 58 Mahiout A, Brunkhorst R: Human mesothelial cells produce 72 kD-gelatinase during exposure to advanced glycosylated (AGE) collagen. Perit Dial Int 15: S11, 1995. 59 Marshall BC, Santana A, Xu QP, Petersen MJ, Campbell EJ, Hoidal JR, Welgus HG: Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. J Clin Invest 91: 1792–1799, 1993. 60 Rougier JP, Moullier P, Piedagnel R, Ronco PM, Guia S: Hyperosmolality suppresses but TGFβ1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51: 337–347, 1997. 61 Shetty S, Kumar A, Johnson A, Idell S: Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 5: 307–314, 1995. 62 Owens MW, Grimes SR: Pleural mesothelial response to inflammation: Tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 265: L382–L388, 1993. 63 Owens MW, Milligan SA: Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived growth factor. Inflammation 18: 77–87, 1994. 64 Douvdevani A, Rappaport J, Konforty A: Human peritoneal mesothelial cells synthesize IL-1α and β. Kidney Int 46: 993–1001, 1994. 65 Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, Lanfrancone L, Mantovani A: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176: 1165–1174, 1992. 66 Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, Mantovani A, Pelicci PG: Human peritoneal mesothelial cells produce many cytokines (Granulocyte colony-stimulating factor (CSF), granulocytemonocyte-CSF, macrophage-CSF, interleukin-1 (IL-1) and IL-6) and are activated and stimulated to grow by IL-1. Blood 80: 2835–2842, 1992. 67 Topley N, Jörres A, Luttmann W, Petersen MM, Lang M, Thierauch K, Muller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα. Kidney Int 43: 226–233, 1993. 68 Topley N, Brown Z, Jörres A: Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1β and tumor necrosis factor-α. Am J Pathol 142: 1876–1886, 1993. 69 Sironi M, Scuacca FL, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F, Mantovani A: Regulation of endothelial and mesothelial function by interleukin-13: Selective induction of vascular cell adhesion molecule-1 and amplification of IL-6 production. Blood 84: 1913–1921, 1994. 70 Betjes MGH, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hart M, Beelen RHJ: Interleukin-8 production by human peritoneal mesothelial cells in response to Tumor Necrosis Factor-α, Interleukin-1, and medium conditioned by macrophages cocultured with staphylococcus epidermis. J Infect Dis 168: 202–210, 1993. 71 Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klingler P, Herold M, Zweierina H, Hittmair A, Mikuz G, Abendstein B, Zeimet A, Marth C: IL-6 secretion by human peritoneal mesothelial cells and ovarian cancer cells. Cytokine 7: 542–547, 1995. 72 Arici A, Tazuke SI, Oral E, Olive DL, Attar E: Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril 67: 1065–1072, 1997. 73 Kinnaert P, De Wilde JP, Bournonville B, Husson C, Salmon I: Direct activation of human peritoneal mesothelial cells by heat-killed microorganisms. Ann Surg 224: 749–755, 1996. 74 Holmes CJ: Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int 46: S58–S70, 1994. 75 Topley N: The cytokine network controlling peritoneal inflammation. Perit Dial Int 15: S35–S40, 1995. 76 Goodman RB, Wood RG, Martin TR, Hanson-Painton O, Kinasewitz GT: Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol 148: 457–465, 1992. 77 Topley N, Williams JD: Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46: S71–S78, 1994. 78 Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD: Expression of colonystimulating factor genes by normal mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74: 940–946, 1989. 79 Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, Kuijpers TW, Roos D, Leguit P, Verbrugh HA: Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 84: 227–232, 1995. 80 Klein CL, Bittinger F, Skarke CC, Wagner M, Köhler H, Walgenbach S, Kirkpatrick CJ: Effects of cytokines on the expression of cell adhesion molecules by cultured human omental mesothelial cells. Pathobiology 63: 204–212, 1995. 81 Liberek T, Topley N, Luttmann W, Williams J: Adherence of neutrophils to human peritoneal mesothelial cells: Role of intercellular adhesion molecule-1. J Am Soc Nephrol 7: 208–217, 1996. 82 Cannistra SA, Ottensmeiter C, Tidy J, DeFranzo B: Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 22: 996–1002, 1994. 83 Bittinger F, Klein CL, Sharke C, Brochhauser C, Walgenbach S, Rohrig O, Kohler H, Kirkpatrick CJ: PECAM-1 expression in human mesothelial cells: An in vitro study. Pathobiology 64: 320–327, 1996. 84 Zeillemaker A, Mul F, Hoynck van Papendrecht A, Leguit P, Verbrugh H, Roos D: Neutrophil adherence to and migration across monolayers of human peritoneal mesothelial cells. J Lab Clin Med 127: 279–286, 1996. 85 Suassuna JHR, Das Neves FC, Hartley RB, Ogg CS, Cameron JS: Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 46: 443–454, 1994. 86 Müller J, Yoshida T: Interaction of murine peritoneal leukocytes and mesothelial cells: In vitro model system to survey cellular events on serosal membranes during inflammation. Clin Immunol Immunopathol 75: 231–2138, 1995. 87 Muijsken MA, Heezius HJCM, Verhoef J, Verbrugh HA: Role of mesothelial cells in peritoneal antibacterial defence. J Clin Pathol 44: 600–604, 1991. 88 Visser CE, Brouwer-Steenbergen JJE, Schadee-Eestermans IL, Meijer S, Krediet RT, Beelen RHJ: Ingestion of Staphylococcus aureus, Staphylococcus epidermis, and Escherichia coli by Human Peritoneal Mesothelial Cells. Infect Immun 64: 3425–3428, 1996. 89 Valle MT, Degl'Innocenti ML, Bertelli R, Facchetti P, Perfumo F, Fenglio D, Kunkl A, Gusmano R, Manca F: Antigen-presenting function of human peritoneum mesothelial cells. Clin Exp Immunol 101: 172–176, 1995. 90 Gjersten M, Saeterdal K, Gaudernack G: Antigen-presenting function of human peritoneum mesothelial cells isolated from a pancreatic carcinoma patient after mutant rats peptide vaccination. Cancer Immunol Immunother 43: 262–268, 1996. 91 Shostak A, Pivnik E, Gotloib L: Cultured Rat Mesothelial Cells Generate Hydrogen Peroxide: A New Player in Peritoneal Defense J Am Soc Nephrol 7: 2371–2378, 1996. 92 Raghow R: The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8: 823–831, 1994. 93 Renvall S, Lehto M, Penttinen R: Development of peritoneal fibrosis occurs under the mesothelial cell layer. J Surg Res 43: 407–412, 1987. 94 Jörres A, Ludat K, Lang J, Sander K, Gahl GM, Frei U, DeJonge K, Williams JD, Topley N: Establishment and functional characterization of human peritoneal fibroblasts in culture: Regulation of Interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 7: 2192–2201, 1996. 95 Jörres A, Ludat K, Sander K, Dunkel K, Lorenz F, Keck H, Frei U, Gahl GM: The peritoneal fibroblast and the control of peritoneal inflammation. Kidney Int 50: S22–S27, 1996. 96 Jörres A, Ludat K, Topley N, Lang J, Sander K, Williams JD, Gahl GM, Frei U: Human peritoneal fibroblasts synthesize the chemotactic peptide interleukin-8 (abstract). Nephron Dial Transplant 9: 1022, 1994. 97 Jörres A, Ludat K, Lang J, Sander K, Gahl GM, Williams JD, Topley N: Human peritoneal fibroblasts synthesize IL-6 in response to IL-1β and TNFα (abstract). Nephron Dial Transplant 8: 1023, 1993. 98 Brown LF, Lanir N, McDonagh J, Dvorak AM, Dvorak HF: Fibroblast migration in fibrin gel matrices. Am J Pathol 142: 273–283, 1993. 99 Hagood JS, Olman MA, Godoy JA, Rivera KE, Fuller GM: Regulation of Type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood 87: 3749–3757, 1996. 100 Beavis MJ, Williams JD, Hoppe J, Topley N: Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 51: 205–215, 1997. 101 Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD: Analysis of peritoneal macrophages in continuous ambulatory dialysis patients. Kidney Int 26: 733–740, 1984. 102 Topley N, Mackenzie RK, Williams JD: Macrophages and mesothelial cells in bacterial peritonitis. Immunobiol 195: 563–573, 1996. 103 Fotev Z, Whitaker D, Papadimitriou JM: Role of macrophages in mesothelial healing. J Pathol 151: 209–219, 1987. 104 Liebman AM, Langer JC, Marshall JS, Collins SM: Role of mast cells in peritoneal adhesion formation. Am J Surg 165: 127–130, 1993. 105 Ramos BF, Zhang Y, Qureshi R, Jakschik BA: Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice. J Immunol 147: 1636–1641, 1991. 106 Shostak A, Chakrabar E, Hirszel P, Maher JF: Effects of histamine and its receptor antagonists on peritoneal permeability. Kidney Int 34: 786–790, 1988. 107 Ito K, Kuwahara M, Sugano S, Kuwahara M: Role of intra- and extracellular calcium stores in mesothelial cell response to histamine. Am J Physiol 268: L63–L70, 1995. 108 Kido H, Fukesen N, Katunuma N, Norita T, Iwanaga S: Tryptase from rat mast cells converts bovine prothrombin to thrombin. Biochem Biophys Res Commun 132: 613–619, 1985. 109 Renkin EM: Cellular and intercellular transport pathways in exchange vessels. Am Rev Respir Dis 146: S28–S31, 1992. 110 Rubin J, Jones Q, Planch A, Stanek K: Systems of membranes involved in peritoneal dialysis. J Lab Clin Med 110: 448–453, 1987. 111 Rippe B, Haraldsson B: Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 74: 163–219, 1994. 112 Carlsson O, Nielsen S, Zakaria ER, Rippe B: In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats. Am J Physiol 271: H2254–H2262, 1996. 113 Roberts W, Palade G: Increased microvascular permeability and endothelial fenestration by vascular endothelial growth factor. J Cell Science 108: 2369–2379, 1995. 114 Feng D, Nagy JA, Dvorak HF, Dvorak AM: Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183: 1981–1986, 1996. 115 Hirszel P, Lameire N, Bogaert M: Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum, in The Textbook of Peritoneal Dialysis, edited by R Gokal, KD. Nolph Dordrecht , The Netherlands , Kluwer Academic Publishers, 1994, pp. 161–232. Citing Literature Volume11, Issue1January 1998Pages 49-56 ReferencesRelatedInformation
Referência(s)